On May 15 – May 18, 2022, this poster was on display at ISPOR 2022.
What is the Objective of this Poster?
- These results help provide insights into which factors are associated with the receipt of TAVR vs. SAVR in the real-world hospital setting.
- After adjusting for baseline characteristics, no notable differences in death, AF, or ABE were observed between TAVR and SAVR cohorts. However, the lack of overlap in patient characteristics between cohorts resulted in a low effective sample sizes, which makes it difficult to detect meaningful differences if they truly existed.
- Additional analyses with an amplified number of patients in the common support region would be needed to provide further insights into the relative safety of these procedures
Register to view this poster now!